Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heparan sulfate and sialic acid-bearing host surfaces represent the glycan-rich layer of the cell membrane, often referred to as the glycocalyx, which plays a pivotal role in mediating interactions between the cell and its environment. Heparan sulfate is a sulfated glycosaminoglycan that interacts with a wide array of protein ligands, including growth factors, chemokines, and viral attachment proteins, thereby regulating physiological processes like angiogenesis and blood coagulation (NIH, 2023). Sialic acids are terminal monosaccharides on glycoproteins and glycolipids that serve as essential recognition markers for biological processes and as primary receptors for many viruses, such as influenza and coronaviruses (PubMed, 2022). In infectious diseases, these surfaces are exploited by pathogens for initial docking and subsequent internalization into host cells (Nature, 2021). Therapeutic strategies targeting these surfaces include the use of glycan mimetics to competitively inhibit pathogen binding or the administration of enzymes to deplete these receptors from the cell surface. For example, sialidases like DAS181 enzymatically remove sialic acids to prevent viral entry, while heparin-like molecules act as decoys for heparan sulfate-binding pathogens (StatPearls, 2023). While effective in preventing infection, targeting these ubiquitous host structures poses challenges regarding specificity and potential interference with normal homeostatic functions. These surfaces are also involved in cancer progression, where altered glycosylation patterns facilitate tumor cell migration and immune evasion (Wikipedia, 2024).
Competitive inhibition of pathogen attachment to host cell surface glycans; enzymatic degradation of cell surface receptors to prevent viral entry; masking of heparan sulfate binding domains.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heparan sulfate and sialic acid-bearing host surfaces.